Board of Directors

Steve Gorlin

Steve Gorlin has founded several biotechnology and pharmaceutical companies, including Hycor Biomedical, Inc. (acquired by Agilent) Read More

Steve Gorlin

Director
Jon Mogford, PhD

Dr. Jon Mogford, has served in various capacities for the Texas A&M University System. Since May 2013, Dr. Mogford has served as the Vice Chancellor for Research, from August 2012.. Read More

Jon Mogford, PhD

Director
Minnie Baylor-Henry, JD

Minnie Baylor-Henry is a regulatory affairs leader who provides regulatory strategic support services to life sciences companies through her consulting firm Read More

Minnie Baylor-Henry, JD

Director
Willie Bogan, JD

Willie Bogan, JD served as Associate General Counsel and Corporate Secretary of McKesson Corporation, a San Francisco-based healthcare services and information technology company. Read More

Willie Bogan, JD

Director
Peter Cohen

Mr. Cohen previously served on the Board of Directors at the NYSE, as well as previously serving as the CEO and Chairman of the Board of Cowen Inc. Read More

Peter Cohen

Director
Jeff Dyer, MBA, PhD

Jeff Dyer is the Horace Beesley professor of strategy at Brigham Young University (BYU), as well as a professor of strategy at the Wharton School, University of Pennsylvania. Read More

Jeff Dyer, MBA, PhD

Director
Ramses (Rainer) Erdtmann

Mr. Erdtmann is a Managing Partner at Point Sur Investors, a biotech investment fund focused on innovative therapies. Read More

Ramses (Rainer) Erdtmann

Director
David Seaburg

Mr. Seaburg is a Managing Director and Head of Sales Trading at Cowen, Inc., a leading healthcare franchise in equities research, sales and trading and investment banking. Read More

David Seaburg

Director
Denver Lough, MD, PhD

Dr. Denver Lough has always sought to investigate reality, pursue complex simplicity and develop a new paradigm in translational science. Read More

Denver Lough, MD, PhD

Chairman of the Board, CEO, Chief R&D Officer